FREQUENT BOLUSING IS ASSOCIATED WITH BETTER GLYCEMIC OUTCOMES IN 7,494 YOUTH WITH TYPE 1 DIABETES USING THE OMNIPOD INSULIN MANAGEMENT SYSTEM

被引：0
|
作者：
Forlenza, G. [1 ]
Desalvo, D. [2 ]
Huyett, L. [3 ]
Jantz, J. [3 ]
Chang, A. [3 ]
Vienneau, T. [3 ]
Ly, T. [3 ]
机构：
[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA
[2] Texas Childrens Hosp, Baylor Coll Med, Pediat Diabet & Endocrinol, Houston, TX 77030 USA
[3] Insulet Corp, Clin, Acton, MA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
439
引用
收藏
页码：A170 / A171
页数：2
相关论文
共 50 条
  • [1] FREQUENT BOLUSING IS ASSOCIATED WITH BETTER GLYCEMIC OUTCOMES IN 4,483 ADULTS WITH TYPE 1 DIABETES USING THE OMNIPOD INSULIN MANAGEMENT SYSTEM
    Hirsch, I.
    Weinstock, R.
    Huyett, L.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A27 - A28
  • [2] Frequent bolusing is associated with better glycaemic outcomes in 4,917 adults with type 1 diabetes using the Omnipod® insulin management system
    Hirsch, I. B.
    Weinstock, R. S.
    Huyett, L.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETIC MEDICINE, 2021, 38
  • [3] REGULAR USERS OF TEMPORARY BASAL RATE OR EXTENDED BOLUS HAVE BETTER GLYCEMIC OUTCOMES IN 11,977 OMNIPOD INSULIN MANAGEMENT SYSTEM USERS WITH TYPE 1 DIABETES
    Weinstock, R.
    Hirsch, I.
    Forlenza, G.
    Desalvo, D.
    Jantz, J.
    Huyett, L.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A179 - A180
  • [4] Real-World Glycemic Outcomes with Early Omnipod 5 Use in Youth with Type 1 Diabetes
    Marks, Brynn E.
    Meighan, Seema
    Zehra, Anum
    Douvas, Julia L.
    Rearson, Andrew
    Suresh, Reshma
    Brown, Elizabeth A.
    Wolf, Risa M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (11) : 782 - 789
  • [5] Effect of the Omnipod® Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII
    Mehta, Sanjeev N.
    Kruger, Davida F.
    Bode, Bruce W.
    Layne, Jennifer E.
    Dumais, Bonnie
    Gallagher, Jack R.
    Ly, Trang T.
    DIABETES, 2019, 68
  • [6] Efficacy of the OmniPod® Insulin Management System on Glycemic Control among Patients with Type 1 Diabetes Previously Treated with MDI or CSII
    Layne, Jennifer E.
    Parkin, Christopher G.
    Zisser, Howard C.
    DIABETES, 2016, 65 : A262 - A262
  • [7] Glycemic Outcomes in Adults with Type 2 Diabetes over 21 Weeks with the Omnipod 5 Automated Insulin Delivery System
    Davis, Georgia M.
    Peters, Anne L.
    Bode, Bruce W.
    Carlson, Anders L.
    Dumais, Bonnie
    Vienneau, Todd
    Huyett, Lauren M.
    Ly, Trang T.
    DIABETES, 2022, 71
  • [8] Recently diagnosed with type 1 diabetes: glycaemic outcomes with the Omnipod® Automated Insulin Delivery System
    Forlenza, G. P.
    DeSalvo, D. J.
    Bode, B. W.
    Criego, A. B.
    Brown, S. A.
    Schoelwer, M. J.
    Mehta, S. N.
    Laffel, L. M.
    MacLeish, S. A.
    Huyett, L. M.
    Boyd, J.
    Gurlin, R. E.
    Ly, T. T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S345 - S345
  • [9] Safety and glycemic outcomes among youth with new onset type 1 diabetes using a tubeless automated insulin delivery system
    DeSalvo, D.
    Sickler, J.
    Villegas, C.
    Kelly, S.
    Wright, V.
    McKay, S.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 122 - 123
  • [10] Youth with Type 1 Diabetes and Their Parents Report Improved Quality of Life with the Omnipod 5 Automated Insulin Delivery System
    Hood, Korey K.
    Polonsky, William H.
    Macleish, Sarah A.
    Levy, Carol J.
    Huyett, Lauren M.
    Vienneau, Todd
    Ly, Trang T.
    DIABETES, 2021, 70
12345